Pre-Clinical Pharmacokinetics, Tissue Distribution and Physicochemical Studies of CLBQ14, a Novel Methionine Aminopeptidase Inhibitor for the Treatment of Infectious Diseases
Oscar Ekpenyong, Xiuqing Gao, Jing Ma, Candace Cooper, Linh Nguyen, Omonike A Olaleye, Dong Liang, Huan Xie Department of Pharmaceutical and Environmental Health Sciences, College of Pharmacy and Health Sciences, Texas Southern University, Houston, TX, USACorrespondence: Huan XieDepartment of Pharma...
Main Authors: | Ekpenyong O, Gao X, Ma J, Cooper C, Nguyen L, Olaleye OA, Liang D, Xie H |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-03-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/pre-clinical-pharmacokinetics-tissue-distribution-and-physicochemical--peer-reviewed-article-DDDT |
Similar Items
-
MapB Protein is the Essential Methionine Aminopeptidase in <i>Mycobacterium tuberculosis</i>
by: Miriam Vanunu, et al.
Published: (2019-04-01) -
Anti-Tuberculosis Potential of OJT008 against Active and Multi-Drug-Resistant Mycobacterium Tuberculosis: In Silico and In Vitro Inhibition of Methionine Aminopeptidase
by: Collins Onyenaka, et al.
Published: (2023-12-01) -
Effect of 8-hydroxyquinoline and derivatives on human neuroblastoma SH-SY5Y cells under high glucose
by: Wilasinee Suwanjang, et al.
Published: (2016-08-01) -
<b>QSAR study of benzimidazole derivatives inhibition on escherichia coli methionine Aminopeptidase</b>
by: Zahra Garkani-Nejad, et al.
Published: (2010-06-01) -
Broad susceptibility of Candida auris strains to 8-hydroxyquinolines and mechanisms of resistance
by: Matthew B. Lohse, et al.
Published: (2023-08-01)